Salvage Therapeutic Radiation With Enzalutamide and ADT in Men With Recurrent Prostate Cancer (STREAM)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Enzalutamide
Related studies linked through entity extraction aliases.
A Randomized Phase IIa Efficacy and Safety Study of Radium-223 Dichloride With Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (CRPC)
- Status
- COMPLETED
- Phase
- PHASE2
Enzalutamide + External Beam Rt For Prostate
- Status
- COMPLETED
- Phase
- PHASE2
Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Enzalutamide and Mifepristone in Treating Patients With Metastatic Hormone Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Safety Study of Continued Enzalutamide Treatment In Prostate Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE4
Neoadjuvant Phase 2 Study Comparing the Effects of AR Inhibition With/Without SRC or MEK Inhibition in Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Sipuleucel-T With Administration of Enzalutamide in Men With Metastatic Castrate-Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Enzalutamide
- Status
- COMPLETED
- Phase
- PHASE4
Enzalutamide in Patients With Androgen Receptor Positive (AR+) Ovarian, Primary Peritoneal or Fallopian Tube Cancer and One, Two or Three Prior Therapies
- Status
- COMPLETED
- Phase
- PHASE2
Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Abiraterone Acetate Plus LHRH Agonist and Abiraterone Acetate Plus LHRH Agonist and Enzalutamide
- Status
- COMPLETED
- Phase
- PHASE2
Study of Enzalutamide in Patients With Castration-resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Enzalutamide in Patients With High-risk Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Tivozanib + Enzalutamide in Adv Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Enzalutamide With or Without Vaccine Therapy for Advanced Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy Study of Enzalutamide Versus Bicalutamide in Men With Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2